Show simple item record

dc.contributor.authorSenok, Abiola C
dc.date.accessioned2021-03-01T08:57:54Z
dc.date.available2021-03-01T08:57:54Z
dc.date.issued2019
dc.identifier.other204-2019.29
dc.identifier.urihttps://repository.mbru.ac.ae/handle/1/183
dc.description.abstractBackground: Significant increase in rates of Clostridioides difficile associated diarrhea (CDI) has been reported globally but there remains a paucity of data from Saudi Arabia. Methodology: Prospective hospital-based surveillance for CDI using the Center for Disease Control (CDC) criteria was conducted from June to November 2015 in a tertiary healthcare facility in Riyadh, Saudi Arabia. Results: During the surveillance period, 106 episodes of CDI were identified among 59 patients in 137,230 patient-days. The incidence of CDI was 3.5 per 10,000 patient days. Of the 106 episodes, 58% (n = 61) were new cases, 12% (n = 13) were recurrent cases and 30% (n = 32) were duplicate cases. Majority of the new cases (n/N = 43/61; 70%)were healthcare onset, followed by community onset (21%) and 8% were community-onset healthcare associated. No statistically significant change in trend was observed during the surveillance period. The most prevalent CDI risk factor was use of proton pump inhibitor (PPI) (92%) followed by prolonged use of antibiotics (77%). Pareto-analysis indicated that controlling for PPI use, prolong and multiple antibiotic exposure and prolonged hospitalization results in 80% CDI reduction. Conclusion: The findings indicate a low incidence of CDI. Multicenter studies are needed to elucidate the burden to CDI in the country.en_US
dc.language.isoenen_US
dc.subjectClostridioides difficileen_US
dc.subjectEpidemiologyen_US
dc.subjectInfection controlen_US
dc.titleClostridioides difficile infection: Incidence and risk factors in a tertiary care facility in Riyadh, Saudi Arabiaen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record